MedTrace Logo

Glycosaminoglycans During Septic Shock - a Temporal Study

NCT00814112 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-03-15

No results posted yet for this study

Summary

We have previously shown that the plasma level of glycosaminoglycans (GAG) in septic shock patients are elevated compared to controls. The purpose of this study is to investigate the temporal dynamic of the blood level of GAG in ten septic shock patients. In addition, to assess the kinetics of GAG during septic shock we examine the liver function by galactose elimination capacity as well as excreted urinary GAG.

Conditions

  • Septic Shock

Sponsors & Collaborators

  • Region Skane

    lead OTHER

Principal Investigators

  • Mikael Bodelsson, professor · Intensive Care Unit, Lund University Hospital, Sweden

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00814112 on ClinicalTrials.gov